Hide metadata

dc.date.accessioned2015-03-03T14:38:10Z
dc.date.available2015-03-03T14:38:10Z
dc.date.created2014-05-26T14:43:52Z
dc.date.issued2014
dc.identifier.citationGjelsvik, Bergljot Heyerdahl, Fridtjof Lunn, Daniel Hawton, Keith . Change in Access to Prescribed Medication following an Episode of Deliberate Self-Poisoning: A Multilevel Approach. PLoS ONE. 2014, 9(5)
dc.identifier.urihttp://hdl.handle.net/10852/42672
dc.description.abstractObjective: Patients with a history of deliberate self-poisoning (DSP) are prescribed a greater amount of medication than the general public. DSP is the most robust risk factor for repeat episodes of DSP and subsequent death by suicide, and one might therefore expect that access to prescribed medication would be reduced following an episode of DSP. However, it is unclear whether access to prescribed medication changes after an episode of DSP. The objectives of this study were to investigate changes in 1) overall, psychotropic, non-psychotropic and the psychotropic subgroup antidepressant prescribed medication availability in DSP patients following an episode of DSP, 2) prescribing of the medication ingested in the episode, and 3) potential effects of gender, age and repeater status on such change. Methods: The design was longitudinal. We included 171 patients admitted for DSP between January 2006 and March 2007. Data on patients' prescriptions prior to admission were retrieved from The Norwegian Prescription Database. The outcome measure was the difference between medication load in the year following compared to the year prior to the DSP episode. Results: There was a significant increase in total medication load following DSP, including both psychotropic and non-psychotropic medication. Antidepressant medication load remained stable. There was a tendency for access to drugs ingested in the episode to increase following the episode, albeit not significantly. Medication load increased with age across all medication groups irrespective of time period and gender. Conclusions: The findings show that physicians do not curb prescribing to patients who have recently deliberately self-poisoned. Moreover, they highlight the need for cautious and judicious prescribing for these patients, in combination with psychological and social interventions.en_US
dc.languageEN
dc.language.isoenen_US
dc.publisherPublic Library of Science (PLoS)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleChange in Access to Prescribed Medication following an Episode of Deliberate Self-Poisoning: A Multilevel Approachen_US
dc.typeJournal articleen_US
dc.creator.authorGjelsvik, Bergljot
dc.creator.authorHeyerdahl, Fridtjof
dc.creator.authorLunn, Daniel
dc.creator.authorHawton, Keith
cristin.unitcode185,17,5,0
cristin.unitnamePsykologisk institutt
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1134954
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLoS ONE&rft.volume=9&rft.spage=&rft.date=2014
dc.identifier.jtitlePLoS ONE
dc.identifier.volume9
dc.identifier.issue5
dc.identifier.doihttp://dx.doi.org/10.1371/journal.pone.0098086
dc.identifier.urnURN:NBN:no-47221
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1932-6203
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/42672/1/journal.pone.0098086.pdf
dc.type.versionPublishedVersion
cristin.articleide98086


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International